HBV Citations List: October 2024

Literature Citations

1. Synthesis of Glucosamine-Selenium Compound and Evaluation of its Oral Toxicity and in vitro Anti-Hepatitis B Virus Activity. Ding, H., X. Lu, X. Ji, S. Wang, J. Jin, M. Zhao, X. Hang and L. Zhao. Chemico- Biological Interactions, 2024. 402: 111184. PMID[39103028].
[PubMed]. HBV­_10_2024.

2. Lappanolides A-N,Ffourteen Undescribed Sesquiterpenoids from Saussurea costus (Syn. Saussurea lappa) and their anti HBV activity. Li, H.B., S.Q. Bai, T.Y. Shu, Q. Wang, H. Chen, L.H. Su and M. Xu. Phytochemistry, 2024. 226: 114207. PMID[38972443].
[PubMed]. HBV­_10_2024.

3. Asiatic Acid Inhibits HBV cccDNA Transcription by Promoting HBx Degradation. Li, R., C. Wang, K. Xu, Z. Zhan, S. He, J. Ren, F. Li, N. Tao, Z. Li, Z. Yang and H. Yu. Virology Journal, 2024. 21(1): 268. PMID[39468627] PMCID[PMC11520515].
[PubMed]. HBV­_10_2024.

4. Control of Hepatitis B Virus with Imdusiran, a Small Interfering RNA Therapeutic. Thi, E.P., X. Ye, N.M. Snead, A.C.H. Lee, H.M. Micolochick Steuer, A. Ardzinski, I.E. Graves, C. Espiritu, A. Cuconati, C. Abbott, A. Jarosz, X. Teng, B. Paratala, K. McClintock, T. Harasym, R. Rijnbrand, A.M. Lam and M.J. Sofia. ACS Infectious Disease, 2024. 10(10): p. 3640-3649. PMID[39306863].
[PubMed]. HBV­_10_2024.

Patent Citations

This month, no relevant HBV patents were identified.